(login)

Leading pharmaceutical
company in the Baltic States

Stock news


2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
«Grindeks» concluded 2013 with profit of 13.83 million euros
28.02.2014

Today, on 28 February, JSC «Grindeks» submitted the non-audited consolidated financial statements for 2013 to “NASDAQ OMX Riga”. Non-audited financial results show that the Group’s turnover amounted to 118.5 million euros in 2013, which is by 0.8 million euros or 1% more than in 2012. In its turn, net profit related to the shareholders of the holding company amounted to 13.8 million euros in 2013, which, in comparison to 2012, has increased by 0.1 million euros or 1%. In 2013, gross profit margin of the Group was 60%, whereas, net profit margin comprised to 11.6%. Products of the Group, manufactured in 2013, were exported to 59 countries worldwide for the total amount of 112.4 million euros, which is by 1.2 million euros or by 1.1% more than in 2012.

Read more


East Capital AB has disposed the holding of the share capital of JSC «Grindeks»
06.02.2014

JSC «Grindeks» informs that it has received the specified notification from the East Capital AB regarding disposal of qualifying holding in the share capital of JSC «Grindeks» in the total amount of 11.28%.

Read more


ABLV Private Equity Fund 2010, KS has acquired 22.66% of the share capital of JSC «Grindeks»
05.02.2014

JSC "«Grindeks»" informs that it has received the notification from the ABLV Private Equity Fund 2010, KS regarding essential acquisition of participation in the share capital of JSC «Grindeks» in the total amount of 22.66% (2 172 437shares) dated on 31 January 2014 .

Read more


Profit of «Grindeks» in the first nine months of 2013 – 5.4 million lats
02.12.2013

Today, on 29 November, the financial statements of the JSC «Grindeks» on the first nine months of 2013, submitted to “NASDAQ OMX Riga”, indicate that the Group’s turnover in the first nine months 2013 was 56.5 million lats, which is by 6.4 million lats or 12.8% more than in the first nine months of 2012. Whereas, the net profit of the Group, related to the shareholders of the holding company, in the first nine months of 2013 was 5.4 million lats that comparing of the first nine months of 2012 has increased by 0.4 million lats or 8%. The gross profit margin in the first nine months of 2013 was 59.5%, whereas, the net profit margin was 9.6%. In the first nine months of 2013 the products manufactured by the Group were exported to 55 countries all over the world for the total amount of 53.6 million lats that comparing to the first nine months of 2012 has increased by 6.2 million lats or 13.1%.

Read more


«Grindeks» invests 1.6 million lats in the Quality control laboratory
27.11.2013

JSC «Grindeks» informs on its investment of 1.6 million lats in the Quality control laboratory, out of which 1.33 million lats will be invested in the construction, but more than 270 thousand lats – in the modern quality control equipment. The project is being carried out to increase the capacity of Microbiology laboratory, which is a unit of Quality control laboratory, and to adapt new pharmaceutical requirements.

Read more